alkylating agents:
	- mechanism: cross links DNA (cell-cycle non-specific)
	- metabolism: liver
	- side effects:
		- myelosuppression
		- hemorrhagic cystitis - high doses (MESNA prevents)
		- AML/MDS + bladder cancer
		- impaired fertility

	- types:	
		- cyclophosphamide:
			- side effects:
				- GI - nausea/vomiting
		- ifosfamide:
			- CNS toxicity
			- renal toxicity

platinums:
	- mechanism: cross links DNA
	- metabolism: non-enzymatic by sulfhydryl groups
	- side effects:
		- neuropathy
		- electrolyte disturbances
		- myelosuppression

	- types:
		- cisplatin:
			- side effects:
				- ototoxicity
				- nephrotoxicity - hydrate!
				- very ematogenic: nausea/vomiting
		- carboplatin:
			- side effects:
				- hypersensitivity reactions
				- 
		- oxaliplatin:
			- side effects:
				- neuropathy worse w/ cold
				- my

antimetabolites:
	- fluorouracil
	- capecitabine
	- gemcitabine
	- methotrexate
anti-microtubules:
	- docetaxel
	- paclitacel
	- vincristine
	- vinblastine
topoisomerase I inhibitors:
	- irinotecan
	- topotecan
topoisomerase II inhibitors:
	- etoposide
anthracyclines:
	- doxorubicin
	- daunorubicin
anti-tumor antibiotics:
	- bleomycin